Psychedelics
The financial institution has given the drug developer a Buy rating a US$12 share target
Hi, what are you looking for?
Mugglehead Investment Magazine
All posts tagged "Deutsche Bank AG"
Silver
Sentiment about whether to hold or sell is alarmingly mixed
